Skip to main content
Signal8

ZACCARDELLI DAVID

SEC insider (Form 3/4/5 filer). CIK 0001627642. Director at Vor Biopharma Inc. (VOR) and 2 other issuers. 46 reported Form 4/5 transactions since Sep 2024; latest on Jul 7, 2026. Located in BOSTON, MA.

Companies ZACCARDELLI DAVID has filed insider reports for

  • Vor Biopharma Inc. (VOR): Director
  • SAB Biotherapeutics, Inc. (SABS): Director
  • Verona Pharma plc (VRNA): Director, Officer, President and CEO
ZACCARDELLI DAVID profile photo

ZACCARDELLI DAVID

CIK: 0001627642

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)26 (56.5%)

Position reduction

Option Exercises (M)5 (10.9%)

Derivative conversions

Awards (A)9 (19.6%)

Compensation grants

Other (G, F, J, C, D, …)6 (13.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Vor Biopharma Inc. logo
VOR

Vor Biopharma Inc.

Director
SAB Biotherapeutics, Inc. logo
SABS

SAB Biotherapeutics, Inc.

Director
Verona Pharma plc logo
VRNA

Verona Pharma plc

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (46 total)

  • Vor Biopharma Inc. logo
    VOR

    Vor Biopharma Inc.

    Jul 7, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    42.7K shares-
  • SAB Biotherapeutics, Inc. logo
    SABS

    SAB Biotherapeutics, Inc.

    Jan 5, 2026
    Award

    Stock Option (right to buy)

    Direct
    240K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Disposition
    Direct
    12.2M shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Award

    Restricted Share Unit

    Direct
    1.6M shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Disposition
    Direct
    3.3M shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Exercise
    Direct
    3.3M shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Aug 29, 2025
    Gift
    Direct
    1.2M shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Aug 1, 2025
    Sale
    Direct
    208.9K shares at avg. $13.14$2.7M
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Aug 1, 2025
    Exercise
    Direct
    255.7K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Jul 8, 2025
    Tax Payment
    Direct
    90.3K shares at avg. $11.44$1.0M

1-10 of 46